Join the Nuplazid group to help and get support from people like you.
Nuplazid News
Acadia Pharmaceuticals Announces FDA Approval of New Dosing Formulation and Strength for Nuplazid (pimavanserin)
SAN DIEGO--(BUSINESS WIRE)--Jun. 29, 2018-- Acadia Pharmaceuticals Inc. today announced FDA approval of a new capsule dose formulation and a new tablet strength of Nuplazid (pimavanserin) to help in...
FDA Approves Nuplazid (pimavanserin) for Parkinson’s Disease Psychosis
April 29, 2016 – The U.S. Food and Drug Administration today approved Nuplazid (pimavanserin) tablets, the first drug approved to treat hallucinations and delusions associated with psychosis...
Ask a question
To post your own question to this support group, sign in or create an account.